InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,303.27
(
0.12%
)
US TECH 100
18,062.00
(
-0.10%
)
Dow Jones
40,003.59
(
0.34%
)
Brent Oil
83.76
(
0.00%
)
Bitcoin
66,890.16
(
-0.08%
)
Post# of 251859
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119662
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 101688

Monday, 08/16/2010 12:27:59 AM

Monday, August 16, 2010 12:27:59 AM

Post# of 251859
IDIX Major Shareholders

[Updated holding of JP Sommadossi.]


The percentages in the table are based on 78.9.M diluted shares,
the count I use for valuation purposes (#msg-49785732); these
percentages differ from the ones reported in SEC filings. 
 
                      Shares    Stake 
 Novartis           31,324,187  39.7% 
 T Rowe Price        8,101,442† 10.3% 
 JP Sommadossi (CEO) 4,026,004*  5.1% 
 BB/MPM Capital      3,321,534   4.2% 
 GlaxoSmithKline     2,474,527   3.1%

†Based on Form 13G filed 5/10/10.
*Includes 1.8M vested and non-vested options.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up